ARTemis: Randomized trial with neoadjuvant chemotherapy for patients with early breast cancer

被引:0
|
作者
Earl, Helena Margaret
Blenkinsop, C.
Grybowicz, L.
Vallier, A-L
Cameron, David A.
Bartlett, John M. S.
Murray, Nicholas
Caldas, Carlos
Thomas, J.
Dunn, Janet A.
Higgins, Helen B.
Hiller, Louise
Hayward, Larry
机构
[1] Univ Cambridge, Dept Oncol, Cambridge, England
[2] NIHR Cambridge Biomed Res Ctr, Cambridge, England
[3] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Canc Trials Ctr, Cambridge, England
[5] Univ Edinburgh, Edinburgh, Midlothian, Scotland
[6] Univ Edinburgh, Edinburgh Canc Res Ctr, Endocrine Canc Grp, Edinburgh, Midlothian, Scotland
[7] SA Hlth Author, Adelaide, SA, Australia
[8] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS1144
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Re: Polychemotherapy for early breast cancer: Results from the International Adjuvant Breast Cancer Chemotherapy Randomized Trial
    Ferretti, Gianluigi
    Felici, Alessandra
    Carlini, Paolo
    Cognetti, Francesco
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18): : 1416 - 1416
  • [42] Neoadjuvant chemotherapy for early breast cancer in young patients: real-world outcomes
    Javed, S. R.
    Mathur, S.
    Desouza, K.
    Konstantis, A.
    Ottaviani, D.
    Raja, F.
    Roylance, R.
    Walsh, T.
    Papadimitraki, E.
    CLINICAL ONCOLOGY, 2025, 38
  • [43] Characterization of circulating tumor cells in early breast cancer patients receiving neoadjuvant chemotherapy
    Jakabova, Anna
    Bielcikova, Zuzana
    Pospisilova, Eliska
    Petruzelka, Lubos
    Blasiak, Piotr
    Bobek, Vladimir
    Kolostova, Katarina
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [44] Emergency Department Presentations in Early Breast Cancer Patients Receiving Adjuvant and Neoadjuvant Chemotherapy
    Tang, M.
    Horsley, P.
    Lewis, C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 74 - 74
  • [45] Identifying changes in mutational dynamics in patients with early breast cancer undergoing neoadjuvant chemotherapy
    Sammut, S. J.
    Chin, S. F.
    Rueda, O. M.
    Dawson, S. J.
    Callari, M.
    Provenzano, E.
    Abraham, J.
    Hughes-Davies, L.
    Earl, H.
    Caldas, C.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S197 - S198
  • [46] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    A. Sverrisdottir
    M. Nystedt
    H. Johansson
    T. Fornander
    Breast Cancer Research and Treatment, 2009, 117
  • [47] Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial
    Sverrisdottir, A.
    Nystedt, M.
    Johansson, H.
    Fornander, T.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) : 561 - 567
  • [48] Time to surgery in early breast cancer treated with neoadjuvant chemotherapy
    Cinausero, M.
    Galli, G.
    Basile, D.
    Gerratana, L.
    Fasola, G.
    De Braud, F.
    Sant, M.
    Paolini, B.
    Di Cosimo, S.
    Puglisi, F.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
    Arriagada, R
    Lê, MG
    Spielmann, M
    Mauriac, L
    Bonneterre, J
    Namer, M
    Delozier, T
    Hill, C
    Tursz, T
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 389 - 396
  • [50] YReal World Responses to Neoadjuvant Chemotherapy for Early Breast Cancer
    Merrick, S.
    Yu, T.
    Papadimitraki, E.
    CLINICAL ONCOLOGY, 2022, 34 (04) : E176 - E176